Jiri Stolfa
Overview
Explore the profile of Jiri Stolfa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bubova K, Storkanova H, Oreska S, Spiritovic M, Hermankova B, Mintalova K, et al.
Biomark Med
. 2021 Jan;
15(1):5-13.
PMID: 33427496
Heat shock protein 90 (Hsp90) is a molecular chaperone regulating immune response. We aimed to assess systemic Hsp90 as a biomarker for spondyloarthritis (SpA). Total of 80 axial SpA (axSpA)...
2.
Kruntoradova K, Klimes J, Sedova L, Stolfa J, Dolezal T, Petrikova A
Value Health Reg Issues
. 2018 Apr;
4:100-106.
PMID: 29702796
Objectives: To determine and compare the impact of rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriasis on work productivity, to calculate the productivity costs (PC), and to map out factors...
3.
Stolfa J
Vnitr Lek
. 2018 Mar;
64(2):127-135.
PMID: 29595278
Psoriatic arthritis (PsA) is a heterogeneous disease affecting, besides synovial joints, also the entheses, the soft tissues of the whole finger (dactylitis) and the axial skeleton. Currently the classification criteria...
4.
Mlcoch T, Tuzil J, Sedova L, Stolfa J, Urbanova M, Suchy D, et al.
Patient
. 2017 Nov;
11(3):329-340.
PMID: 29164493
Background: Clinical trials and observational studies lacking measures of health-related quality of life (QoL) are often inapplicable when conducting cost-effectiveness analyses using quality-adjusted life-years (QALYs). The only solution is to...
5.
Mlcoch T, Sedova L, Stolfa J, Urbanova M, Suchy D, Smrzova A, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2016 Jun;
17(2):203-211.
PMID: 27291258
Aim: To map health-related quality of life (Qol) with clinical parameters BASFI and ASDAS-CRP measure, and other covariates. Methods: Our prospective multicenter non-interventional observation study of ankylosing spondylitis (AS) collected...
6.
Husakova M, Lippert J, Stolfa J, Sedova L, Arenberger P, Lacinova Z, et al.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
. 2015 Jul;
159(4):562-8.
PMID: 26175050
Background And Aims: Psoriasis vulgaris (PV) is complicated in up to 40% patients by the inflammatory joint disease psoriatic arthritis (PsA). Neither the aetiology of the arthritis nor specific laboratory...
7.
Behrens F, Finkenwirth C, Pavelka K, Stolfa J, Sipek-Dolnicar A, Thaci D, et al.
Arthritis Care Res (Hoboken)
. 2012 Oct;
65(3):464-70.
PMID: 23042698
Objective: To determine the "real-world" clinical effectiveness and safety of leflunomide in patients with psoriatic arthritis (PsA). Methods: This prospective, multinational 24-week observational study involved adult patients with active PsA...
8.
Cibulova A, Zajacova M, Fojtikova M, Stolfa J, Sedova L, Cejkova P, et al.
Rheumatol Int
. 2012 Jul;
33(4):913-9.
PMID: 22821332
Psoriatic arthritis (PsA) affects approximately 30 % of patients suffering from psoriasis vulgaris (PsV), but the risk factors for its development have not been well elucidated yet. The HLA-Cw*06 allele...
9.
HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population
Fojtikova M, Stolfa J, Novota P, Cejkova P, Dostal C, Cerna M
Rheumatol Int
. 2009 Feb;
29(11):1293-9.
PMID: 19184033
Psoriatic arthritis (PsA) is a chronic inflammatory joint disease which affects patients suffering from psoriasis. The genetic background especially the susceptibility loci on the short arm of the chromosome six...
10.
Stolfa J, Fojtikova M, Cejkova P, Cerna M, Sedova L, Dostal C
Rheumatol Int
. 2007 Jun;
27(11):1095-6.
PMID: 17564716
No abstract available.